Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving J&J vaccine

A blood clot is less risky than Covid says CDC

The risk of dying from Covid-19 is 40 times the risk of developing a rare blood clotting condition after getting the Johnson & Johnson vaccine, a CNN analysis shows.

The US Centers for Disease Control and Prevention said Wednesday it has received reports of 28 people who have developed a rare blood clotting syndrome out of 8.7 million given J&J's Janssen coronavirus vaccine. Three of them have died from the condition, known as thrombosis with thrombocytopenia syndrome (TTS).

However, in that same time period -- March 2 to May 7 -- more than 2.2 million people were diagnosed with Covid-19 and more than 43,000 died, according to data from Johns Hopkins University.
In a group of about 8.7 million people, that scales to nearly 59,000 new Covid-19 cases reported in the past two months and nearly 1,150 new Covid-19 deaths, more than 40 times the number of reported and confirmed cases of TTS.

The chances that a person vaccinated with the J&J vaccine will develop TTS are less than one in 300,000, according to CDC data. But in the past two months, about one in every 7,600 Americans has died of Covid-19.
The CDC has said TTS is plausibly linked to J&J's Janssen vaccine but has said the benefits of the vaccine nonetheless outweigh the risk. All cases have been seen in people ages 18 to 59.

"Most of these TTS cases are occurring in the 30-49-year-old age group," CDC's Dr. Tom Shimabukuro told a meeting of the CDC's Advisory Committee on Immunization Practices.

While most cases were among women, six cases were reported among men, Shimabukuro said. He said 19 had a type of brain blood clot called thrombosis of the cerebral venous sinus, or CVST, while others had different types of blood clots.

The CDC has alerted doctors and patients about the possibility of the complication so it can be recognized and treated promptly and properly.
"There were no cases with a known or documented coagulation disorder," Shimabukuro said. That indicates it's difficult to predict who might develop the condition.
Get CNN Health's weekly newsletter
Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.

"It is important to recognize TTS early and initiate appropriate treatment," he added. "TTS is a rare, clinically serious and life-threatening condition."
TTS has also been linked to AstraZeneca's coronavirus vaccine, which is not authorized for use in the US but is in wide use in Britain and Europe.

Tags : #JJVaccine #Covid19Vaccine #JohnsonandJohnson #CDC #FDA #CovidVaccine

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023